Exhibit 1 JOINT FILING AGREEMENT In accordance with Rule 13d-1(k) (1) (iii) under the Securities Exchange Act of 1934, as amended, the persons named below agree to the joint filing on behalf of each of them of a Statement on Schedule 13G/A filed on...Joint Filing Agreement • June 10th, 2003 • Genome Therapeutics Corp • In vitro & in vivo diagnostic substances
In accordance with Rule 13d-1(k) (1) (iii) under the Securities Exchange Act of 1934, as amended, the persons named below agree to the joint filing on behalf of each of them of a Statement on Schedule 13G/A filed on June 10, 2003 (including amendments thereto) with respect to the common stock of Genome Therapeutics Corp.
